HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Satyendra Prakash, Speaker at Vaccines Conferences
Indian Institute of Information Technology, India
Title : mRNA-based nanomedicine: An innovative approach for treating infectious diseases and beyond

Abstract:

Messenger RNA (mRNA) has emerged as a groundbreaking therapeutic agent for the prevention and treatment of a wide range of diseases. The recent development of lipid nanoparticle-mRNA vaccines by Moderna and Pfizer-BioNTech against COVID-19 in record time underscores the enormous potential of mRNA technology, reshaping the landscape of vaccine development and the future of gene therapies.

My presentation will explore the revolutionary role of mRNA in modern medicine, emphasizing the success stories of the COVID-19 mRNA nanomedicines. It will delve into the rapid development processes and the profound impact these vaccines have had globally. Furthermore, the discussion will address key challenges associated with mRNA therapeutics, including translational efficacy, mRNA stability, immunogenicity, and quality control.

In addition, the advancements in mRNA engineering and delivery systems have significantly improved these aspects, making mRNA a viable and effective option for therapeutic applications. Thus, the presentation will highlight the latest innovations that have incrementally overcome these challenges, providing an overview of the state-of-the-art in mRNA technology.

Audience Take Away Notes:

  • Yes, the audience will gain a comprehensive understanding of the potential and challenges of mRNA technology, the innovations driving its progress, and the future directions in this rapidly advancing field. This knowledge I believe will be invaluable for researchers and also for professionals involved in biomedical research, vaccine development, and other therapeutic innovations.
  • Yes, the audience will gain a comprehensive understanding of the potential and challenges of mRNA technology, the innovations driving its progress, and the future directions in this rapidly advancing field. This knowledge I believe will be invaluable for researchers and also for professionals involved in biomedical research, vaccine development, and other therapeutic innovations.
  • Yes, researchers can expand their research portfolios with new insights on mRNA technology. Also, this presentation will provide up-to-date information on mRNA advancements.
  • Benefit fields like vaccine development, gene therapy, and personalized medicine against cancers and many other diseases.

Biography:

Mr. Prakash studied Biotechnology at the University of Allahabad, India, and graduated with an M.Sc. in 2021. He was a Department of Biotechnology (DBT) fellow for two years, from 2019 to 2021. He then joined the research groups in the Department of Chemical Engineering at the Indian Institute of Technology, (IIT) Roorkee, India, where he is pursuing graduate studies. He has published six articles in SCI(E) journals.

Watsapp